[
  {
    "ts": null,
    "headline": "Pfizer Receives Expanded FDA Approval for Cancer Treatment",
    "summary": "Pfizer Receives Expanded FDA Approval for Cancer Treatment",
    "url": "https://finnhub.io/api/news?id=24365f2790bf9a89d5f4a56ed6d39e587ede882fc165ebaf7dba4f12c2cb73ab",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1739364000,
      "headline": "Pfizer Receives Expanded FDA Approval for Cancer Treatment",
      "id": 132683286,
      "image": "",
      "related": "PFE",
      "source": "MarketWatch",
      "summary": "Pfizer Receives Expanded FDA Approval for Cancer Treatment",
      "url": "https://finnhub.io/api/news?id=24365f2790bf9a89d5f4a56ed6d39e587ede882fc165ebaf7dba4f12c2cb73ab"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer: 3 Key Risks That Warrant A Sell",
    "summary": "Pfizer faces revenue decline from patent expirations, profitability challenges, and bearish technicals. Learn why PFE stock is a Sell.",
    "url": "https://finnhub.io/api/news?id=133e8660169a4138d856a661bbe6f2404d9ac349fb98693af9164caf67af1bcb",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1739340295,
      "headline": "Pfizer: 3 Key Risks That Warrant A Sell",
      "id": 132678968,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/487533661/image_487533661.jpg?io=getty-c-w1536",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "Pfizer faces revenue decline from patent expirations, profitability challenges, and bearish technicals. Learn why PFE stock is a Sell.",
      "url": "https://finnhub.io/api/news?id=133e8660169a4138d856a661bbe6f2404d9ac349fb98693af9164caf67af1bcb"
    }
  }
]